Davis Polk advised the representatives of the initial purchasers in the offering and also advised the counterparties on capped call transactions. Bloom Energy Corporation (NYSE: BE)...
Bloom Energy’s $632.5 Million Green Convertible Notes and Capped Call Transactions
Mirion Technologies’ $52.9 Million Secondary Offering
Davis Polk advised the underwriter on the transaction. Mirion Technologies announced the $52.9 million offering of 7,000,000 shares of Class A common stock of Mirion Technologies,...
ACELYRIN’s $621 Million Initial Public Offering
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
DexCom’s $1.25 Billion Convertible Notes Offering and Capped Call Transactions
Fenwick advised DexCom on the offering, while Davis Polk advised the representatives of the initial purchasers and the counterparties to the capped call transactions. DexCom, Inc....
AVITA Medical’s At-The-Market Offering
K&L Gates advised AVITA, and Davis Polk advised the sales agent for the offering. AVITA Medical, Inc. announced the establishment of an SEC-registered at-the-market program of...
Equinix’s ¥77.28 Billion Senior Notes Private Placement
Davis Polk advised Equinix Inc. on the offering. Equinix, Inc. announced the private placement of ¥77.28 billion aggregate principal amount of senior notes by its wholly...
Mirion Technologies’ $85.6 Million Secondary Offering
Goodwin Procter advised Mirion Technologies on the offering, and Davis Polk advised the underwriter. Mirion Technologies announced the $85.6 million offering of 9,786,153 shares of its Class...
Revolution Medicines’ $345 Million Common Stock Public Offering
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
Mirion Technologies’ $150 Million Direct Offering of Common Stock
Davis Polk advised Mirion Technologies on the offering. Mirion Technologies, Inc. announced a registered direct offering of 17,142,857 shares of its Class A common stock at...
RxSight’s $50 Million Common Shares Offering
Wilson Sonsini advised RxSight, and Davis Polk advised the sole bookrunning manager in the offering. RxSight, Inc. announced a $50 million SEC-registered follow-on offering of 4,000,000...
Xponential Fitness’ $122.5 Million Secondary Offering of Class A Common Stock
Davis Polk is advising Xponential Fitness on the offering, and Latham & Watkins is advising the underwriters involved. Xponential Fitness, Inc. has announced the pricing of...
Pacific Biosciences’ $201.25 Million Stock Offering
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...